Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the ability of sirolimus to prevent graft versus
host disease (GVHD) in patients following stem cell transplant from a related donor.